2 assets in Hepatic Metastasis, Non-Human Animal

Therapeutic assets addressing Hepatic Metastasis, Non-Human Animal, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
L-Cysteinamide, D-Phenylalanyl-L-Cysteinyl-L-Phenylalanyl-D-Tryptophyl-L-Lysyl-L-Threonyl-N-(2-Hydroxy-1-(Hydroxymethyl)Propyl)-, Cyclic (2->7)-Disulfide, (R-(R,R))- Hepatic Metastasis, Non-Human Animal	Clinica Universidad de Navarra, Universidad de Navarra	P2	CCC (53)
Sti-1386 Hepatic Metastasis, Non-Human Animal	Sorrento Therapeutics, Inc.	P1	CC (43)